Both serum EGFR and EGF demonstrated good diagnostic capacity in LC patients in a previous study [35] whilst the role of HB-EGF in LC has only been assessed in terms of response to EGFR treatment [36]. The gene discussed is GSTM1; the disease is laryngotracheoesophageal cleft.